News

News FDA releases scientific evidence on the presence of opioid compounds in kratom

2/09/2018
  • Drug Control Program
  • Board of Registration in Pharmacy
  • Bureau of Health Professions Licensure

FDA Statement

FDA releases adverse events and scientific analysis providing even stronger evidence of kratom compounds’ opioid properties.

Additional Resources for FDA releases scientific evidence on the presence of opioid compounds in kratom

Drug Control Program 

We promote access to safe and effective pharmaceutical care services in Massachusetts. We work to protect consumers against fraud, deception, and unsafe practices in the distribution, handling, and use of pharmaceuticals and medical devices.

Board of Registration in Pharmacy 

We track, provide codes for, and set quality standards for pharmacists, pharmacy interns, and pharmacy technicians.

Bureau of Health Professions Licensure 

BHPL oversees the licensing of health care professionals in the state of Massachusetts.

Feedback

Did you find what you were looking for on this webpage? * required
We use your feedback to help us improve this site but we are not able to respond directly. Please do not include personal or contact information. If you need a response, please locate the contact information elsewhere on this page or in the footer.
We use your feedback to help us improve this site but we are not able to respond directly. Please do not include personal or contact information. If you need a response, please locate the contact information elsewhere on this page or in the footer.

If you need to report child abuse, any other kind of abuse, or need urgent assistance, please click here.

Feedback